This is a routine ATM capacity update with no new information on use of proceeds or business developments. Monitor future ATM sales disclosures and any clinical trial catalysts for the company's pipeline.
Price Chart
Executive Summary
NanoViricides filed Amendment No. 2 to its ATM prospectus supplement, updating the maximum remaining offering amount to $2.37 million under its existing S-3 shelf. The company has already sold ~$12.0 million in common stock via the ATM over the prior 12 months, and this amendment simply recalculates the available capacity under the one-third-of-public-float rule. This is a routine administrative update with no new fundamental information.
Key Facts
- Maximum remaining ATM offering amount: $2,374,774
- Already sold ~$12,012,443 in common stock via ATM in prior 12 months
- Public float as of Oct 19, 2026: $43,161,651 (25,539,439 non-affiliate shares at $1.69)
- Stock listed on NYSE under NNVC; closing price $1.69 on Sep 21, 2026
- Offering conducted through D. Boral Capital LLC as sales agent
- No new shares registered; only updates capacity under existing S-3 (File 333-296550)
Financial Impact
Up to $2.37 million in potential additional common stock sales at market prices
Risk Factors
- Continued ATM sales will dilute existing shareholders
- Company has no revenue and an auditor going-concern qualification (per prior filings)
- At current market cap (~$43M float), even $2.37M in additional sales represents ~5.5% dilution
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001104659-26-117595 |
| Document: 0001104659-26-117595-index-headers.html | 0001104659-26-117595 |
| Document: 0001104659-26-117595-index.html | 0001104659-26-117595 |
| Document: 0001104659-26-117595.txt | 0001104659-26-117595 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 424B5 | $1.51 | awaiting T+60 | — | $1.40 (−7.28%) |
Oct 8, 2026 18d ago | DEF 14A | $1.31 | awaiting T+60 | — | $1.40 (+6.87%) |
Jul 27, 2026 13w ago | 424B5 | $1.54 $1.48 | ▲ +3.90% | ▲ +7.95% | $1.40 (+9.09%) |
Jul 27, 2026 13w ago | 424B5 | $1.54 $1.48 | ▼ −3.90% | ▼ −7.95% | $1.40 (−9.09%) |
Jun 29, 2026 17w ago | EFFECT | $1.37 $1.51 | ▼ −10.22% | ▼ −6.60% | $1.40 (−2.19%) |
Jun 16, 2026 18w ago | EFFECT | $1.36 $1.02 | ▼ −25.00% | ▼ −26.86% | $1.40 (+2.94%) |
Jun 15, 2026 19w ago | S-3 | $1.36 $1.02 | ▼ −25.00% | ▼ −26.86% | $1.40 (+2.94%) |
Jun 5, 2026 20w ago | S-3 | $1.43 $1.17 | ▲ +18.18% | ▲ +21.69% | $1.40 (+2.10%) |
May 18, 2026 23w ago | 424B5 | $1.51 $1.37 | ▲ +9.27% | ▲ +14.12% | $1.40 (+7.28%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers